1.
Silverberg JI, Simpson EL, Boguniewicz M, De Bruin-Weller MS, Foley P, Kataoka Y, et al. Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis. Acta Derm Venereol [Internet]. 2021 Nov. 10 [cited 2024 Nov. 25];101(11):adv00585. Available from: https://medicaljournalssweden.se/actadv/article/view/307